Resultaten visas 1 - 10 / 833
resultat / per sida
Vilka publikationsuppgifter finns i tjänsten?
Publikationens namn
Upphovspersoner
Publikationskanal
År
Publicationer information ikon

Prognostic biomarkers in pancreatic ductal adenocarcinoma

Saukkonen, Kapo
[K. Saukkonen]2018Publicationer information ikon

Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities

Referentgranskad
Öppen tillgång
DOI
10.1016/j.canlet.2024.216859
Qin Qin; Rong Yu; John E. Eriksson; Hsiang i. Tsai; Haitao Zhu
Cancer Letters2024Publicationer information ikon

Weak HIF-1 alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma

Referentgranskad
Öppen tillgång
DOI
10.1186/s12957-018-1432-4
Leppänen, Joni;Helminen, Olli;Huhta, Heikki;Kauppila, Joonas H.;Isohookana, Joel;Haapasaari, Kirsi-M...
World journal of surgical oncology2018Publicationer information ikon

Neoadjuvant therapy and prognostic factors in pancreatic ductal adenocarcinoma

Öppen tillgång
Nurmi, Anna
Helsingin yliopisto2021Publicationer information ikon

Emerging novel prognostic markers in pancreatic ductal adenocarcinoma

Öppen tillgång
Isohookana, Joel
Acta Universitatis Ouluensis. Series D, Medica2018Publicationer information ikon

TKTL1 as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma and Its Correlation with FDG-PET-CT

Referentgranskad
Öppen tillgång
DOI
10.1159/000510862
Ahopelto, Kaisa; Saukkonen, Kapo; Hagström, Jaana; Kauhanen, Saila; Seppänen, Hanna; Böckelman, Cami...
Oncology2021Publicationer information ikon

PROX1 and beta-catenin are prognostic markers in pancreatic ductal adenocarcinoma

Referentgranskad
Öppen tillgång
DOI
10.1186/s12885-016-2497-5
Saukkonen, Kapo; Hagstrom, Jaana; Mustonen, Harri; Juuti, Anne; Nordling, Stig; Kallio, Pauliina; Al...
Bmc cancer2016Publicationer information ikon

Prognostic and differential diagnostic biomarkers in pancreatic ductal adenocarcinoma

Öppen tillgång
Lanki, Mira
Helsingin yliopisto2023Publicationer information ikon

Pancreatic ductal adenocarcinoma : the role of tumor-associated macrophages and systemic inflammatory response

Salmiheimo, Aino
[A. Salmiheimo]2017Publicationer information ikon

Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma

Referentgranskad
Öppen tillgång
DOI
10.1097/MPA.0000000000001195
Leppänen, Joni; Lindholm, Ville; Isohookana, Joel; Haapasaari, Kirsi-Maria; Karihtala, Peeter; Lehen...
Pancreas2019

Prognostic biomarkers in pancreatic ductal adenocarcinoma

2018

Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities

Referentgranskad
Öppen tillgång
DOI
10.1016/j.canlet.2024.216859
2024

Weak HIF-1 alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma

Referentgranskad
Öppen tillgång
DOI
10.1186/s12957-018-1432-4
2018

Neoadjuvant therapy and prognostic factors in pancreatic ductal adenocarcinoma

Öppen tillgång
2021

Emerging novel prognostic markers in pancreatic ductal adenocarcinoma

Öppen tillgång
2018

TKTL1 as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma and Its Correlation with FDG-PET-CT

Referentgranskad
Öppen tillgång
DOI
10.1159/000510862
2021

PROX1 and beta-catenin are prognostic markers in pancreatic ductal adenocarcinoma

Referentgranskad
Öppen tillgång
DOI
10.1186/s12885-016-2497-5
2016

Prognostic and differential diagnostic biomarkers in pancreatic ductal adenocarcinoma

Öppen tillgång
2023

Pancreatic ductal adenocarcinoma : the role of tumor-associated macrophages and systemic inflammatory response

2017

Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma

Referentgranskad
Öppen tillgång
DOI
10.1097/MPA.0000000000001195
2019